trending Market Intelligence /marketintelligence/en/news-insights/trending/tjwjel-sl1ovojjacft20q2 content esgSubNav
In This List

ReShape Lifesciences director resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


ReShape Lifesciences director resigns

ReShape Lifesciences Inc. said Michael Mashaal resigned from its board of directors.

The San Clemente, Calif.-based medical device company said Mashaal's resignation was not due to any disagreement with ReShape Lifesciences.